These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7663659

  • 1. [Clinical development of rhDNase in the United States].
    Eisenberg J.
    Arch Pediatr; 1995 Jul; 2(7):674-8. PubMed ID: 7663659
    [Abstract] [Full Text] [Related]

  • 2. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
    Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME.
    N Engl J Med; 1994 Sep 08; 331(10):637-42. PubMed ID: 7503821
    [Abstract] [Full Text] [Related]

  • 3. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis.
    Shak S.
    Chest; 1995 Feb 08; 107(2 Suppl):65S-70S. PubMed ID: 7842816
    [Abstract] [Full Text] [Related]

  • 4. Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study Group.
    Harms HK, Matouk E, Tournier G, von der Hardt H, Weller PH, Romano L, Heijerman HG, FitzGerald MX, Richard D, Strandvik B, Kolbe J, Kraemer R, Michalsen H.
    Pediatr Pulmonol; 1998 Sep 08; 26(3):155-61. PubMed ID: 9773909
    [Abstract] [Full Text] [Related]

  • 5. [Multicenter study of rhDNase in cystic fibrosis with severe pulmonary involvement].
    Hodson M.
    Arch Pediatr; 1995 Jul 08; 2(7):679-81. PubMed ID: 7663660
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical studies of rhDNase in moderately and severely affected patients with cystic fibrosis--an overview.
    Hodson ME.
    Respiration; 1995 Jul 08; 62 Suppl 1():29-32. PubMed ID: 7792438
    [Abstract] [Full Text] [Related]

  • 10. Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatment.
    Shah PI, Bush A, Canny GJ, Colin AA, Fuchs HJ, Geddes DM, Johnson CA, Light MC, Scott SF, Tullis DE.
    Eur Respir J; 1995 Jun 08; 8(6):954-8. PubMed ID: 7589382
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis.
    Shah PL, Scott SF, Knight RA, Marriott C, Ranasinha C, Hodson ME.
    Thorax; 1996 Feb 08; 51(2):119-25. PubMed ID: 8711640
    [Abstract] [Full Text] [Related]

  • 13. Where we are now with rhDNase.
    Geddes DM, Shah PL.
    Lancet; 1999 May 22; 353(9166):1727. PubMed ID: 10347981
    [No Abstract] [Full Text] [Related]

  • 14. Effect of a short course of rhDNase on cough and mucociliary clearance in patients with cystic fibrosis.
    Robinson M, Hemming AL, Moriarty C, Eberl S, Bye PT.
    Pediatr Pulmonol; 2000 Jul 22; 30(1):16-24. PubMed ID: 10862158
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis.
    Ranasinha C, Assoufi B, Shak S, Christiansen D, Fuchs H, Empey D, Geddes D, Hodson M.
    Lancet; 1993 Jul 24; 342(8865):199-202. PubMed ID: 8100928
    [Abstract] [Full Text] [Related]

  • 16. New treatment strategies in cystic fibrosis: rhDNase.
    Shah PL, Hodson ME.
    Monaldi Arch Chest Dis; 1996 Apr 24; 51(2):125-9. PubMed ID: 8680379
    [Abstract] [Full Text] [Related]

  • 17. [Effect of rhDNase on the respiratory function and nutritional status of children and adolescents with mucoviscidosis].
    Wizla-Derambure N, Michaud L, Sardet A, Deschildre A, Loeuille GA, Tassin E, Loire N, Buisine C, Boutry E, Dias J, Hecquet F, Turck D.
    Arch Pediatr; 1998 Apr 24; 5(4):378-83. PubMed ID: 9759156
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability.
    Wills PJ, Wodehouse T, Corkery K, Mallon K, Wilson R, Cole PJ.
    Am J Respir Crit Care Med; 1996 Aug 24; 154(2 Pt 1):413-7. PubMed ID: 8756815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.